Clinical Trial Update: Resveratrol Trial for Relief of Pain in Pseudoachondroplasia [Phase 2]

View source ↗

Summary

Phase 2 trial of resveratrol for relief of pain in pseudoachondroplasia was terminated; results posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pseudoachondroplasia

Drugs mentioned

• Resveratrol (resveratrol)

Snippet

Sponsor: The University of Texas Health Science Center, Houston | Conditions: Pseudoachondroplasia | Phase 2 | Status: TERMINATED | Results posted: 2022-12-09